Paulo G. Leite
Belo Horizonte, MG, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Structure-based discovery of novel cruzain inhibitors with distinct trypanocidal activity profiles.
Journal: European journal of medicinal chemistry
Published: January 27, 2023
SOCS2 regulates alveolar bone loss in Aggregatibacter actinomycetemcomitans-induced periodontal disease.
Journal: Inflammation research : official journal of the European Histamine Research Society ... [et al.]
Published: November 03, 2022
Role of formyl peptide receptor 2 (FPR2) in modulating immune response and heart inflammation in an experimental model of acute and chronic Chagas disease.
Journal: Cellular immunology
Published: March 26, 2021
Structural design, synthesis and anti-Trypanosoma cruzi profile of the second generation of 4-thiazolidinones chlorine derivatives.
Journal: Chemico-biological interactions
Published: December 22, 2020
Tityus serrulatus scorpion venom as a potential drug source for Chagas' disease: Trypanocidal and immunomodulatory activity.
Journal: Clinical immunology (Orlando, Fla.)
Published: August 19, 2020
Discovery and characterization of trypanocidal cysteine protease inhibitors from the 'malaria box'.
Journal: European journal of medicinal chemistry
Published: May 06, 2019
Role of SOCS2 in the Regulation of Immune Response and Development of the Experimental Autoimmune Encephalomyelitis.
Journal: Mediators of inflammation
Published: April 03, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026